Transplantation and the CD28/CTLA4/B7 pathway

Transplant Proc. 2001 Feb-Mar;33(1-2):209-11. doi: 10.1016/s0041-1345(00)01977-1.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Abatacept
  • Animals
  • Antigen-Presenting Cells / immunology
  • Antigens, CD / immunology
  • Antigens, Differentiation / pharmacology*
  • B7-1 Antigen / immunology
  • B7-2 Antigen
  • CD28 Antigens / immunology*
  • CTLA-4 Antigen
  • Cell Movement
  • Graft Rejection / immunology
  • Graft Survival / drug effects
  • Humans
  • Immunity, Cellular
  • Immunoconjugates*
  • Immunosuppressive Agents / pharmacology*
  • Intestines / transplantation
  • Lymphocyte Activation
  • Membrane Glycoproteins / immunology
  • Mice
  • Receptors, Antigen, T-Cell / immunology*
  • T-Lymphocytes / drug effects*
  • T-Lymphocytes / immunology
  • Transplantation Tolerance / immunology*

Substances

  • Antigens, CD
  • Antigens, Differentiation
  • B7-1 Antigen
  • B7-2 Antigen
  • CD28 Antigens
  • CD86 protein, human
  • CTLA-4 Antigen
  • CTLA4 protein, human
  • Cd86 protein, mouse
  • Ctla4 protein, mouse
  • Immunoconjugates
  • Immunosuppressive Agents
  • Membrane Glycoproteins
  • Receptors, Antigen, T-Cell
  • Abatacept